Jasper Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Jasper Therapeutics
JSPR Stock  USD 22.31  0.09  0.40%   
Jasper Therapeutics financial statements provide useful quarterly and yearly information to potential Jasper Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Jasper Therapeutics financial statements helps investors assess Jasper Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Jasper Therapeutics' valuation are summarized below:
Market Capitalization
337.1 M
Earnings Share
(4.75)
There are over one hundred fourteen available fundamental trends for Jasper Therapeutics, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to confirm Jasper Therapeutics' regular fundamental performance against the performance between 2010 and 2024 to make sure the trends are evolving in the right direction.
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 8.4 M or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Jasper Therapeutics Correlation against competitors.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Jasper Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets63.2 M94.9 M39.7 M
Slightly volatile
Other Current Liabilities3.7 M6.3 M2.2 M
Slightly volatile
Total Current Liabilities7.4 M12.4 M3.9 M
Slightly volatile
Other Liabilities2.2 M2.3 M4.7 M
Pretty Stable
Net Tangible Assets57.6 M32.4 M84 M
Slightly volatile
Warrants69 M71.4 M87.3 M
Slightly volatile
Accounts Payable2.6 M4.1 M1.3 M
Slightly volatile
Cash56.5 M86.9 M37.2 M
Slightly volatile
Non Current Assets Total4.6 M6 M1.7 M
Slightly volatile
Non Currrent Assets Other1 M1.8 M404.3 K
Slightly volatile
Cash And Short Term Investments56.5 M86.9 M37.2 M
Slightly volatile
Common Stock Total Equity2.4 K4.6 K1.3 K
Slightly volatile
Short Term Investments80.1 M90.1 M98.2 M
Slightly volatile
Liabilities And Stockholders Equity62.3 M94.9 M36.9 M
Slightly volatile
Non Current Liabilities Total3.9 M4.1 M7.9 M
Pretty Stable
Capital Surpluse81.2 M162.3 M38.9 M
Slightly volatile
Other Current Assets1.9 M1.8 M910 K
Slightly volatile
Total Liabilities18.2 M16.5 M10 M
Slightly volatile
Long Term Investments110.3 M115.4 M101.9 M
Slightly volatile
Total Current Assets58.6 M88.9 M38 M
Slightly volatile
Non Current Liabilities Other2.2 M2.3 M4.3 M
Pretty Stable
Common Stock95010007.4 K
Slightly volatile
Short and Long Term Debt Total3 M2.8 M2 M
Slightly volatile
Property Plant And Equipment Net4.5 M4.2 M2.8 M
Slightly volatile
Long Term Debt10.5 M11.8 M12.9 M
Slightly volatile
Net Receivables412.2 K250 K564.9 K
Slightly volatile
Common Stock Shares Outstanding11 M10.4 M1.9 M
Slightly volatile
Long Term Debt Total10.5 M11.8 M12.9 M
Slightly volatile
Capital Lease Obligations3 M2.8 M2 M
Slightly volatile
Property Plant And Equipment Gross5.2 M6.7 M3 M
Slightly volatile
Capital Stock2 K10001.5 K
Slightly volatile
Net Working Capital57.1 M76.6 M28.8 M
Slightly volatile
Property Plant Equipment3.8 M4.1 M2.6 M
Slightly volatile
Current Deferred Revenue2.2 M2.5 M2.8 M
Slightly volatile
Short Term Debt1.7 M1.9 M1.2 M
Slightly volatile

Jasper Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.2 M1.1 M3.4 M
Slightly volatile
Selling General Administrative11.2 M17.1 M4.8 M
Slightly volatile
Other Operating Expenses40 M68.9 M17.5 M
Slightly volatile
Research Development28.9 M51.8 M12.9 M
Slightly volatile
Total Operating Expenses40 M68.9 M17.5 M
Slightly volatile
Cost Of Revenue826.4 K1.1 M269.4 K
Slightly volatile
Net Interest Income3.2 M5.2 M1.2 M
Slightly volatile
Interest Income3.2 M5.2 M1.2 M
Slightly volatile
Selling And Marketing Expenses886.4 K997.2 K1.1 M
Slightly volatile

Jasper Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings61.6 K64.8 K1 M
Slightly volatile
Stock Based Compensation5.5 M5.2 M1.1 M
Slightly volatile
Begin Period Cash Flow37.6 M38.7 M13.9 M
Slightly volatile
Depreciation628.8 K1.1 M458.7 K
Slightly volatile
Capital Expenditures253.7 K267 K2 M
Slightly volatile
Total Cash From Financing Activities53.3 M101 M37.2 M
Slightly volatile
End Period Cash Flow56.8 M87.3 M37.3 M
Slightly volatile
Change To Liabilities442.5 K465.8 K701.9 K
Pretty Stable
Issuance Of Capital Stock61.9 M116.7 M27.6 M
Slightly volatile
Other Cashflows From Investing Activities158.7 K178.5 K194.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.230.2415.223
Slightly volatile
Payables Turnover0.230.26710.103
Slightly volatile
Cash Per Share7.918.323359.2433
Slightly volatile
Days Payables Outstanding1.3 K1.4 K18.4 K
Slightly volatile
Income Quality0.660.80770.5539
Slightly volatile
Net Debt To EBITDA1.231.294265.8159
Slightly volatile
Current Ratio9.437.187511.6616
Slightly volatile
Graham Number30.732.3119437
Slightly volatile
Debt To Equity0.01170.01240.009
Slightly volatile
Capex Per Share0.02430.02561.7186
Slightly volatile
Interest Debt Per Share0.08850.09310.3825
Slightly volatile
Debt To Assets0.0090.01020.0068
Slightly volatile
Price Earnings To Growth Ratio0.20.18820.0632
Slightly volatile
Days Of Payables Outstanding1.3 K1.4 K18.4 K
Slightly volatile
Ebt Per Ebit1.120.95981.0511
Pretty Stable
Effective Tax Rate0.02340.02460.0417
Slightly volatile
Total Debt To Capitalization0.01140.01220.0089
Slightly volatile
Debt Equity Ratio0.01170.01240.009
Slightly volatile
Quick Ratio9.447.187511.6652
Slightly volatile
Net Income Per E B T0.640.97540.7767
Pretty Stable
Cash Ratio9.147.021711.5582
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.00511.0675
Pretty Stable
Debt Ratio0.0090.01020.0068
Slightly volatile

Jasper Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap19.3 M20.3 M75.4 M
Slightly volatile

Jasper Fundamental Market Drivers

Cash And Short Term Investments86.9 M

Jasper Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Jasper Therapeutics Financial Statements

Jasper Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Jasper Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Jasper Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Jasper Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.5 M2.2 M
Cost Of Revenue1.1 M826.4 K

Pair Trading with Jasper Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Jasper Stock

  0.72IMAB I MabPairCorr
  0.51GNFT GenfitPairCorr
  0.47LLY Eli LillyPairCorr
  0.47PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.4FLGC Flora Growth CorpPairCorr
The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.
The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY